Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses. (4th November 2015) - Heery, Christopher R; Donahue, Renee; Lepone, Lauren; Grenga, Italia; Richards, Jacob; Metenou, Simon; Fernando, Romaine I; Dirmeier, Ulrike; Singh, Harpreet; Madan, Ravi; Gulley, James L; Schlom, Jeffrey